F

Fresenius Medical Care

Operates dialysis facilities and renal care

Vice President CDC R&D and Innovation

Full-TimeDeadline 12/31/26
No salary listed
Expert
Suzhou, Jiangsu, China
Hybrid
Engineering ManagementEngineering Leadership

About the job

Requirements
  • Deep experience in localization engineering, product adaptation, and China-specific design requirements.
  • A proven track record in sustained engineering, including cost-down engineering, quality improvements, and reliability engineering.
  • A strong understanding of lifecycle management in regulated industries.
  • Fluency in China regulatory frameworks, including NMPA, cybersecurity law, and data localization.
  • Strong experience in product development, innovation management, and translating customer or market needs into technically feasible solutions.
  • The ability to evaluate technical options and contribute to make-or-buy decisions.
  • Demonstrated ability to lead cross-functional teams in a global matrix environment.
  • The capability to collaborate with Verticals, Manufacturing, and China business leadership.
  • Experience navigating global governance, platform strategies, and shared technology roadmaps.
  • Experience negotiating with and managing external Chinese development and operations partners.
  • The ability to build partnerships and ecosystems across internal functions and external technology organizations.
  • A deep understanding of China’s med-tech ecosystem, innovation landscape, and competitive dynamics.
  • Experience working within a multinational corporation in China, ideally with China-first innovation mandates.
  • The ability to balance independence with global alignment.
  • The ability to translate China market needs, customer insights, and ecosystem developments into strategic product and technology priorities.
  • The ability to deliver fast, high-quality engineering outcomes in China.
  • The ability to manage complex product portfolios across the full life cycle.
  • The ability to lead complex, end-to-end product initiatives involving multiple functions, technologies, and external partners.
Responsibilities
  • Drive end-to-end localization of global products for China, including engineering, testing, and regulatory alignment from market requirement definition through development, validation, launch, and post-market improvements.
  • Lead China innovation aligned with Verticals, local market needs, government priorities, and the five-year plan.
  • Establish independent decision-making while maintaining alignment with Value Streams and Verticals.
  • Establish a management framework with local external partners to ensure China goals are met.
  • Own technical content development of China product innovations, including identifying, prioritizing, and driving China-specific innovations and smaller-scale product enhancements that address local customer needs and market opportunities.
  • Translate China market requirements, customer insights, and unmet needs into actionable product concepts and engineering priorities.
  • Build and leverage external innovation ecosystems, including technology partners, digital solution providers, universities, research institutions, and other strategic partners, to accelerate localization and innovation.
  • Identify and integrate digital technologies, software capabilities, AI-enabled solutions, and data-driven approaches where they enhance product value, customer experience, and operational performance.
  • Lead sustained engineering activities for China, including product updates, cost optimizations, quality improvements, and reliability enhancements.
  • Manage lifecycle management for China-market products, ensuring compliance, continuity, and timely updates across the product’s lifespan.
  • Lead root-cause analysis, corrective actions, and continuous improvement initiatives for China-specific product or portfolio issues.
  • Ensure alignment with Verticals and global lifecycle strategies while adapting to China’s regulatory and market requirements.
  • Own the continuous evolution of China products by translating market feedback, technology developments, regulatory changes, and customer insights into product improvements throughout the lifecycle.
  • Provide engineering and technology perspectives to support portfolio decisions, lifecycle investments, and product optimization priorities.
  • Build strong interfaces with Verticals and Value Streams to ensure platform consistency, shared technology roadmaps, coordinated development, and alignment of China adaptations and innovations with global product strategies.
  • Partner with China Commercial, Manufacturing, Procurement, Quality, and Regulatory teams to ensure seamless execution.
  • Collaborate with the Global Medical Office to identify and enable clinical innovation opportunities, including clinical studies, evidence generation, and China-specific clinical requirements supporting product strategies.
  • Support make-or-buy decisions by providing technical assessments and recommendations, balancing internal capabilities, external partnerships, speed, cost, quality, regulatory requirements, and strategic importance.
  • Ensure alignment across R&D, Digital, Clinical, Commercial, Manufacturing, Procurement, and external ecosystems to enable transition from innovation concepts to market implementation.
  • Build and lead a high-performing local engineering and design team with China-specific capabilities.
  • Create a fast, agile operating model tailored to China’s innovation pace.
  • Represent the China Design Center to government bodies, innovation hubs, and strategic partners.
  • Establish the China Design Center as a recognized center of technical expertise, product innovation, and engineering excellence, with accountability for shaping product direction and accelerating China-specific solutions.
  • Develop an operating model that enables faster decision-making, stronger local ownership, and effective collaboration with global platforms and technology strategies.
  • Foster a culture of innovation, digital mindset, and ecosystem collaboration within the China Design Center.
Desired Qualifications
  • Experience with digital products, software-enabled solutions, connected products, AI, data platforms, or technology ecosystems.
  • Experience with clinical innovation, evidence generation, or collaboration with medical functions in a regulated healthcare environment.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...